BROMOCRIPTINE IN THE MANAGEMENT OF END OF DOSE DETERIORATION IN PARKINSONS-DISEASE

被引：12

作者：

GRIMES, JD

KING, DB

KOFMAN, OS

MOLINANEGRO, P

WILSON, AF

BOUCHARD, S

机构：

[1] NOTRE DAME HOSP, MONTREAL, QUEBEC, CANADA

[2] SANDOZ CANADA, MONTREAL, QUEBEC, CANADA

[3] ROYAL ALEXANDRA HOSP, EDMONTON, ALBERTA, CANADA

[4] VICTORIA GEN HOSP, HALIFAX B3H 2Y9, NS, CANADA

[5] OTTAWA CIVIC HOSP, OTTAWA K1Y 4E9, ONTARIO, CANADA

[6] MT SINAI HOSP, TORONTO M5G 1X5, ONTARIO, CANADA

来源：

关键词：

D O I：

10.1017/S0317167100045996

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：452 / 456

页数：5

共 27 条

[1] BARBEAU A, 1971, LANCET, V1, P395
[2] CALNE DB, 1978, LANCET, V1, P735
[3] A METHOD FOR EVALUATING DISABILITY IN PATIENTS WITH PARKINSONS-DISEASE
CANTER, GJ
DELATORRE, R
MIER, M
[J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 1961, 133 (02) : 143 - 147
[4] DUVOISIN RC, 1971, MONOAMINES NOYAUX GR, P313
[5] FAHN S, 1982, MOVEMENT DISORD, V8, P123
[6] THE EFFECT OF BROMOCRIPTINE (BCT) ON THE ON-OFF PHENOMENON
GLANTZ, R
GOETZ, CG
NAUSIEDA, PA
WEINER, WJ
KLAWANS, HL
[J]. JOURNAL OF NEURAL TRANSMISSION, 1981, 52 (1-2) : 41 - 47
[7] GRANERUS AK, 1978, ACTA MED SCAND, V203, P75
[8] GRIMES JD, 1983, CAN J NEUROL SCI, V10, P86
[9] GRIMES JD, 1984, CAN J NEUROL SCI, V11, P225
[10] METHOD OF ADDITION OF BROMOCRIPTINE TO THE DRUG REGIME OF PATIENTS WITH ADVANCED PARKINSONS-DISEASE
GRIMES, JD
HASSAN, MN
[J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1981, 8 (01) : 31 - 34